How to treat Alzheimer?

Éist leis an leathanach seo

Conas alzheimer a chóireáil?

Níl aon leigheas ar ghalar Alzheimer, ach tá roinnt roghanna cóireála ar fáil chun cabhrú leis na hairíonna a bhainistiú agus dul chun cinn an ghalair a mhoilliú.

I measc cuid de na cóireálacha seo tá:

1. Leigheas: Tá roinnt cógais ar fáil a d'fhéadfadh cabhrú le hairíonna ghalair Alzheimer a bhainistiú.

Áirítear orthu seo coscóirí cholinesterase, mar donepezil, rivastigmine, agus galantamine, a d'fhéadfadh cabhrú le feidhmiú cognaíoch agus cuimhne a fheabhsú.

Is cógais eile é Memantine a d'fhéadfadh cabhrú le feidhmiú cognaíoch agus le hairíonna iompraíochta.

2. Athruithe ar stíl mhaireachtála: Is féidir le cleachtadh fisiciúil rialta a dhéanamh, aiste bia sláintiúil a ithe, agus naisc shóisialta a chothabháil cabhrú le sláinte agus folláine foriomlán a fheabhsú do dhaoine a bhfuil galar Alzheimer orthu.

3. Teiripeanna cognaíocha agus iompraíochta: Is féidir le teiripeanna cognaíocha, mar shampla teiripe spreagadh cognaíoch, cabhrú le feidhmiú cognaíoch agus cuimhne a fheabhsú i ndaoine a bhfuil galar Alzheimer orthu.

Is féidir le teiripeanna iompraíochta, mar shampla teiripe iompraíochta cognaíoch, cabhrú le hairíonna iompraíochta a bhainistiú agus cáilíocht na beatha a fheabhsú.

4. Cúram tacaíochta: Is féidir le cúram tacaíochta, mar shampla teiripe fostaíochta, teiripe cainte, agus teiripe fisiceach, cabhrú le daoine a bhfuil galar Alzheimer acu a neamhspleáchas agus a fheidhm a choinneáil chomh fada agus is féidir.

5. Trialacha cliniciúla: Is féidir le rannpháirtíocht i dtrialacha cliniciúla le haghaidh cóireálacha agus teiripeanna nua rochtain a thabhairt ar chóireálacha ceannródacha agus cuidiú le cur le forbairt cóireálacha nua le haghaidh galar Alzheimer.

Tá sé tábhachtach oibriú go dlúth le soláthraí cúraim sláinte chun plean cóireála aonair a fhorbairt le haghaidh galar Alzheimer, ós rud é gur féidir le riachtanais agus comharthaí gach duine a bheith éagsúil.

Ina theannta sin, tá sé ríthábhachtach tacaíocht mhothúchánach a sholáthar agus cúram a thabhairt don duine a bhfuil galar Alzheimer air agus dá gcúramóirí araon.

Tagairtí

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Kumar A, Singh A, Aggarwal A: Therapeutic potentials of herbal drugs for Alzheimer’s disease—An overview. Indian J Exp Biol. 2017, 55 (2): 63-73.

Sutor B, Rasmussen KG: Electroconvulsive therapy for agitation in Alzheimer disease: a case series. J ECT. 2008, 24 (3): 239-41.

Boada M, Ramos-Fernández E, Guivernau B, Muñoz FJ, Costa M, Ortiz AM, Jorquera JI, Núñez L, Torres M, Páez A: Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: Rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study. Neurologia. 2016, 31 (7): 473-81.

Golde TE: The Abeta hypothesis: leading us to rationally-designed therapeutic strategies for the treatment or prevention of Alzheimer disease. Brain Pathol. 2005, 15 (1): 84-7.

Giacobini E: Therapy of Alzheimer disease: symptomatic or neuroprotective? J Neural Transm Suppl. 1994, 43 (): 211-7.

Burke AD, Goldfarb D: Facilitating Treatment Initiation in Early-Stage Alzheimer Disease. J Clin Psychiatry. 2022, 83 (4): .

Haussmann R, Donix M: [Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]. Nervenarzt. 2017, 88 (1): 40-45.

Diúltú freagrachta: leighis

Cuirtear an suíomh gréasáin seo ar fáil chun críocha oideachais agus faisnéise amháin agus ní sholáthraíonn sé comhairle leighis nó seirbhísí gairmiúla.

Níor cheart an t-eolas a chuirtear ar fáil a úsáid chun fadhb sláinte nó galar a dhiagnóisiú nó a chóireáil, agus ba cheart dóibh siúd atá ag lorg comhairle leighis phearsanta dul i gcomhairle le dochtúir ceadúnaithe.

Tabhair faoi deara le do thoil go bhfuil an líonra néarónach a ghineann freagraí ar na ceisteanna, míchruinn go háirithe nuair a bhaineann sé le hábhar uimhriúil. Mar shampla, líon na ndaoine a ndearnadh diagnóis orthu le galar ar leith.

Déan comhairle do dhochtúir nó do sholáthraí sláinte cáilithe eile i gcónaí maidir le riocht leighis. Ná déan neamhaird ar chomhairle leighis ghairmiúil ná déileáil leis mar gheall ar rud éigin a léigh tú ar an suíomh Gréasáin seo. Má cheapann tú go bhféadfadh éigeandáil leighis a bheith agat, glaoigh ar 911 nó téigh go dtí an seomra éigeandála is gaire láithreach. Ní chruthaíonn an suíomh Gréasáin seo ná a úsáid aon chaidreamh dochtúir-othar. Ní dhéanann BioMedLib ná a chuid fostaithe, ná aon ranníocóir leis an suíomh Gréasáin seo aon ionadaíochtaí, sainráite nó intuigthe, maidir leis an bhfaisnéis a sholáthraítear anseo ná a úsáid.

Diúltú freagrachta: cóipchirt

Soláthraíonn an Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (an DMCA) aisíocaíocht do úinéirí cóipchirt a chreideann go sáraíonn ábhar atá le feiceáil ar an Idirlíon a gcearta faoi dhlí cóipchirt na Stát Aontaithe.

Má chreideann tú go dea-chreidimh go sáraíonn aon ábhar nó ábhar a chuirtear ar fáil i ndáil lenár suíomh Gréasáin nó lenár seirbhísí do chóipcheart, féadfaidh tú (nó do ghníomhaire) fógra a sheoladh chugainn ag iarraidh an t-ábhar nó an t-ábhar a bhaint, nó rochtain air a bhac.

Ní mór fógraí a sheoladh i scríbhinn trí ríomhphost (féach an rannán "Contact" le haghaidh seoladh ríomhphoist).

Éilíonn an DMCA go gcuimsíonn do fhógra faoi shárú cóipchirt líomhain an fhaisnéis seo a leanas: (1) cur síos ar an saothar cóipchirt atá ina ábhar don shárú líomhain; (2) cur síos ar an ábhar líomhain atá ag sárú líomhain agus faisnéis leordhóthanach chun ligean dúinn an t-ábhar a aimsiú; (3) faisnéis teagmhála duit, lena n-áirítear do sheoladh, uimhir theileafóin agus seoladh ríomhphoist; (4) ráiteas uait go bhfuil creideamh maith agat nach bhfuil an t-ábhar ar an mbealach a bhfuil gearán á dhéanamh air údaraithe ag úinéir cóipchirt, nó a ghníomhaire, nó ag oibriú aon dlí;

(5) ráiteas uait, arna shíniú faoi phionós perjury, go bhfuil an t-eolas sa fhógra cruinn agus go bhfuil an t-údarás agat na cóipchearta a éilítear a shárú a fhorfheidhmiú;

agus (6) síntiús fisiciúil nó leictreonach úinéir an chóipchirt nó duine údaraithe chun gníomhú thar ceann úinéir an chóipchirt.

D'fhéadfadh moill a bheith ar phróiseáil do ghearán mura gcuirfidh tú an t-eolas thuas go léir san áireamh.

Cumarsáid

Seol ríomhphost dúinn le haon cheist / moladh le do thoil.

How to treat alzheimer?

There is no cure for Alzheimer's disease, but there are several treatment options available to help manage the symptoms and slow the progression of the disease.

Some of these treatments include:

1. Medications: There are several medications available that can help manage the symptoms of Alzheimer's disease.

These include cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, which can help improve cognitive function and memory.

Memantine is another medication that can help with cognitive function and behavioral symptoms.

2. Lifestyle changes: Engaging in regular physical exercise, eating a healthy diet, and maintaining social connections can help improve overall health and well-being for people with Alzheimer's disease.

3. Cognitive and behavioral therapies: Cognitive therapies, such as cognitive stimulation therapy, can help improve cognitive function and memory in people with Alzheimer's disease.

Behavioral therapies, such as cognitive behavioral therapy, can help manage behavioral symptoms and improve quality of life.

4. Supportive care: Supportive care, such as occupational therapy, speech therapy, and physical therapy, can help people with Alzheimer's disease maintain their independence and function as long as possible.

5. Clinical trials: Participating in clinical trials for new treatments and therapies can provide access to cutting-edge treatments and help contribute to the development of new treatments for Alzheimer's disease.

It is important to work closely with a healthcare provider to develop an individualized treatment plan for Alzheimer's disease, as the needs and symptoms of each person can vary.

Additionally, it is essential to provide emotional support and care for both the person with Alzheimer's disease and their caregivers.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.

Timpeall

Úsáideann BioMedLib ríomhairí uathoibrithe (algorithms foghlama meaisín) chun péirí ceisteanna agus freagraí a ghiniúint.

Tosaímid le 35 milliún foilseachán bithleighis de PubMed/Medline. Chomh maith le leathanaigh ghréasáin de RefinedWeb.

Féach "Tuairiscí" freisin "Disclaimer".